On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.